Antonios Nikitidis — 7 Patents at Astrazeneca Ab

Antonios Nikitidis has been granted 7 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 2011 and the most recent in March 2021. Antonios Nikitidis ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Antonios Nikitidis in Lund, SE.

Patents per Year

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
10961236	(S)-2-(1-cyclopropylethyl)-5-(4-methyl-2-((6-(2-oxopyrrolidin-1-yl)pyridin-2-yl)amino) thiazol-5-yl)-7-(methylsulfonyl)isoindolin-1-one as a phosphatidylinositol 3-kinase inhibitor	Matthew Perry, Christian Tyrchan, Konstantinos KARABELAS, Mickael Mogemark, Jens PETERSEN +2 more	2021-03-30	$54,443,000
9657001	Compounds and uses	Robert Rönn, Carl Jonas Lindh, Erik Ringberg, Hanna Birgitta Ellinor Andersson, Peter Nilsson +5 more	2017-05-23	$33,284,000
8501784	2-pyridone derivatives as neutrophil elastase inhibitors and their use	Marjana Andersson, Peter Hansen, Hans Roland LONN, Petter Sjölin	2013-08-06	$10,790,000
8466284	Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase	David M. Chapman, Martin Lindsjö, Hans Roland LONN, Michael Lundkvist, Magnus Munck Af Rosenschöld +2 more	2013-06-18	$5,074,000
8410114	2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial	Peter Hansen, Marianne Ivarsson, Karolina Lawitz, Hans Roland LONN, Asim Ray	2013-04-02	$12,291,000
8114881	2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial	Peter Hansen, Marianne Ivarsson, Karolina Lawitz, Hans Roland LONN, Asim Ray	2012-02-14	$6,101,000
8063073	2-pyridone derivatives as neutrophil elastase inhibitors and their use	Peter Hansen, Hans Roland LONN	2011-11-22	$3,731,000